Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Aug;87(15):5893–5897. doi: 10.1073/pnas.87.15.5893

Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension.

F Catella 1, J A Lawson 1, D J Fitzgerald 1, G A FitzGerald 1
PMCID: PMC54435  PMID: 2198572

Abstract

Arachidonic acid is metabolized by means of P450 isoenzyme(s) to form epoxyeicosatrienoic acids (EETs) and their corresponding dihydroxy derivatives (DHETs). In the present study, we established the presence in human urine of 8,9-, 11,12-, and 14,15-EETs and their corresponding DHETs by developing quantitative assays and using negative ion, chemical ionization GC/MS and octadeuterated internal standards. Urinary excretion of 8,9- and 11,12-DHET increased in healthy pregnant women compared with nonpregnant female volunteers. By contrast, excretion of 11,12-DHET and 14,15-DHET, but not the 8,9-DHET regioisomer, increased even further in patients with pregnancy-induced hypertension. Intravenous administration of [3H]14,15-EET to three dogs markedly increased its DHET in plasma. The terminal half-life ranged from 7.9-12.3 min and the volume of distribution (3.5-5.3 liters) suggested limited distribution outside the plasma compartment. Negligible radioactivity was detected in urine; this fact infers that under physiological circumstances, urinary DHETs largely derive from the kidney. That P450 metabolites of arachidonic acid are formed in humans supports the hypothesis that these metabolites contribute to the physiological response to normal pregnancy and the pathophysiology of pregnancy-induced hypertension.

Full text

PDF
5893

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaufils M., Uzan S., Donsimoni R., Colau J. C. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet. 1985 Apr 13;1(8433):840–842. doi: 10.1016/s0140-6736(85)92207-x. [DOI] [PubMed] [Google Scholar]
  2. Benigni A., Gregorini G., Frusca T., Chiabrando C., Ballerini S., Valcamonico A., Orisio S., Piccinelli A., Pinciroli V., Fanelli R. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med. 1989 Aug 10;321(6):357–362. doi: 10.1056/NEJM198908103210604. [DOI] [PubMed] [Google Scholar]
  3. Capdevila J., Marnett L. J., Chacos N., Prough R. A., Estabrook R. W. Cytochrome P-450-dependent oxygenation of arachidonic acid to hydroxyicosatetraenoic acids. Proc Natl Acad Sci U S A. 1982 Feb;79(3):767–770. doi: 10.1073/pnas.79.3.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carroll M. A., Schwartzman M., Capdevila J., Falck J. R., McGiff J. C. Vasoactivity of arachidonic acid epoxides. Eur J Pharmacol. 1987 Jun 19;138(2):281–283. doi: 10.1016/0014-2999(87)90445-6. [DOI] [PubMed] [Google Scholar]
  5. Chiou W. L. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve. J Pharmacokinet Biopharm. 1978 Dec;6(6):539–546. doi: 10.1007/BF01062108. [DOI] [PubMed] [Google Scholar]
  6. Davey D. A., MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988 Apr;158(4):892–898. doi: 10.1016/0002-9378(88)90090-7. [DOI] [PubMed] [Google Scholar]
  7. Falck J. R., Schueler V. J., Jacobson H. R., Siddhanta A. K., Pramanik B., Capdevila J. Arachidonate epoxygenase: identification of epoxyeicosatrienoic acids in rabbit kidney. J Lipid Res. 1987 Jul;28(7):840–846. [PubMed] [Google Scholar]
  8. FitzGerald G. A., Pedersen A. K., Patrono C. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation. 1983 Jun;67(6):1174–1177. doi: 10.1161/01.cir.67.6.1174. [DOI] [PubMed] [Google Scholar]
  9. Fitzgerald D. J., Entman S. S., Mulloy K., FitzGerald G. A. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation. 1987 May;75(5):956–963. doi: 10.1161/01.cir.75.5.956. [DOI] [PubMed] [Google Scholar]
  10. Fitzgerald D. J., Mayo G., Catella F., Entman S. S., FitzGerald G. A. Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets. Am J Obstet Gynecol. 1987 Aug;157(2):325–330. doi: 10.1016/s0002-9378(87)80162-x. [DOI] [PubMed] [Google Scholar]
  11. Fitzgerald D. J., Rocki W., Murray R., Mayo G., FitzGerald G. A. Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet. 1990 Mar 31;335(8692):751–754. doi: 10.1016/0140-6736(90)90869-7. [DOI] [PubMed] [Google Scholar]
  12. Fitzpatrick F. A., Ennis M. D., Baze M. E., Wynalda M. A., McGee J. E., Liggett W. F. Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry. J Biol Chem. 1986 Nov 15;261(32):15334–15338. [PubMed] [Google Scholar]
  13. Gallery E. D., Rowe J., Brown M. A., Ross M. Effect of changes in dietary sodium on active electrolyte transport by erythrocytes at different stages of human pregnancy. Clin Sci (Lond) 1988 Feb;74(2):145–150. doi: 10.1042/cs0740145. [DOI] [PubMed] [Google Scholar]
  14. Gant N. F., Daley G. L., Chand S., Whalley P. J., MacDonald P. C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973 Nov;52(11):2682–2689. doi: 10.1172/JCI107462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hirt D. L., Capdevila J., Falck J. R., Breyer M. D., Jacobson H. R. Cytochrome P450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting duct. J Clin Invest. 1989 Dec;84(6):1805–1812. doi: 10.1172/JCI114365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Karara A., Dishman E., Blair I., Falck J. R., Capdevila J. H. Endogenous epoxyeicosatrienoic acids. Cytochrome P-450 controlled stereoselectivity of the hepatic arachidonic acid epoxygenase. J Biol Chem. 1989 Nov 25;264(33):19822–19827. [PubMed] [Google Scholar]
  17. Laniado-Schwartzman M., Davis K. L., McGiff J. C., Levere R. D., Abraham N. G. Purification and characterization of cytochrome P-450-dependent arachidonic acid epoxygenase from human liver. J Biol Chem. 1988 Feb 15;263(5):2536–2542. [PubMed] [Google Scholar]
  18. Leithauser M. T., Roerig D. L., Winquist S. M., Gee A., Okita R. T., Masters B. S. Omega-hydroxylation of prostaglandin E1 in the isolated perfused lungs of pregnant rabbits. Prostaglandins. 1988 Dec;36(6):819–833. doi: 10.1016/0090-6980(88)90059-7. [DOI] [PubMed] [Google Scholar]
  19. Masters B. S., Okita R. T., Muerhoff A. S., Leithauser M. T., Gee A., Winquist S., Roerig D. L., Clark J. E., Murphy R. C., Ortiz de Montellano P. Pulmonary P-450-mediated eicosanoid metabolism and regulation in the pregnant rabbit. Adv Prostaglandin Thromboxane Leukot Res. 1989;19:335–338. [PubMed] [Google Scholar]
  20. McKay D. G. Chronic intravascular coagulation in normal pregnancy and preeclampsia. Contrib Nephrol. 1981;25:108–119. doi: 10.1159/000396020. [DOI] [PubMed] [Google Scholar]
  21. Morrison A. R., Pascoe N. Metabolism of arachidonate through NADPH-dependent oxygenase of renal cortex. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7375–7378. doi: 10.1073/pnas.78.12.7375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Oliw E. H., Guengerich F. P., Oates J. A. Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediates. J Biol Chem. 1982 Apr 10;257(7):3771–3781. [PubMed] [Google Scholar]
  23. Oliw E. H., Lawson J. A., Brash A. R., Oates J. A. Arachidonic acid metabolism in rabbit renal cortex. Formation of two novel dihydroxyeicosatrienoic acids. J Biol Chem. 1981 Oct 10;256(19):9924–9931. [PubMed] [Google Scholar]
  24. Patel L., Sullivan M. H., Elder M. G. Production of epoxygenase metabolite by human reproductive tissues. Prostaglandins. 1989 Dec;38(6):615–624. doi: 10.1016/0090-6980(89)90044-0. [DOI] [PubMed] [Google Scholar]
  25. Rochat R. W., Koonin L. M., Atrash H. K., Jewett J. F. Maternal mortality in the United States: report from the Maternal Mortality Collaborative. Obstet Gynecol. 1988 Jul;72(1):91–97. [PubMed] [Google Scholar]
  26. Rosolowsky M., Falck J. R., Willerson J. T., Campbell W. B. Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries. Circ Res. 1990 Mar;66(3):608–621. doi: 10.1161/01.res.66.3.608. [DOI] [PubMed] [Google Scholar]
  27. Rákóczi I., Tallián F., Bagdány S., Gáti I. Platelet life-span in normal pregnancy and pre-eclampsia as determined by a non-radioisotope technique. Thromb Res. 1979;15(3-4):553–556. doi: 10.1016/0049-3848(79)90161-0. [DOI] [PubMed] [Google Scholar]
  28. Sacerdoti D., Escalante B., Abraham N. G., McGiff J. C., Levere R. D., Schwartzman M. L. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science. 1989 Jan 20;243(4889):388–390. doi: 10.1126/science.2492116. [DOI] [PubMed] [Google Scholar]
  29. Sachs B. P., Brown D. A., Driscoll S. G., Schulman E., Acker D., Ransil B. J., Jewett J. F. Maternal mortality in Massachusetts. Trends and prevention. N Engl J Med. 1987 Mar 12;316(11):667–672. doi: 10.1056/NEJM198703123161105. [DOI] [PubMed] [Google Scholar]
  30. Schiff E., Peleg E., Goldenberg M., Rosenthal T., Ruppin E., Tamarkin M., Barkai G., Ben-Baruch G., Yahal I., Blankstein J. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med. 1989 Aug 10;321(6):351–356. doi: 10.1056/NEJM198908103210603. [DOI] [PubMed] [Google Scholar]
  31. Schwartzman M. L., Balazy M., Masferrer J., Abraham N. G., McGiff J. C., Murphy R. C. 12(R)-hydroxyicosatetraenoic acid: a cytochrome-P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8125–8129. doi: 10.1073/pnas.84.22.8125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schwartzman M. L., Falck J. R., Yadagiri P., Escalante B. Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolites. J Biol Chem. 1989 Jul 15;264(20):11658–11662. [PubMed] [Google Scholar]
  33. Schwartzman M., Ferreri N. R., Carroll M. A., Songu-Mize E., McGiff J. C. Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase. Nature. 1985 Apr 18;314(6012):620–622. doi: 10.1038/314620a0. [DOI] [PubMed] [Google Scholar]
  34. Sebaldt R. J., Kreeft J. H. Efficient pharmacokinetic modeling of complex clinical dosing regimens: the universal elementary dosing regimen and computer algorithm EDFAST. J Pharm Sci. 1987 Feb;76(2):93–100. doi: 10.1002/jps.2600760202. [DOI] [PubMed] [Google Scholar]
  35. Toto R., Siddhanta A., Manna S., Pramanik B., Falck J. R., Capdevila J. Arachidonic acid epoxygenase: detection of epoxyeicosatrienoic acids in human urine. Biochim Biophys Acta. 1987 Jun 2;919(2):132–139. doi: 10.1016/0005-2760(87)90199-8. [DOI] [PubMed] [Google Scholar]
  36. Turk J., Wolf B. A., Comens P. G., Colca J., Jakschik B., McDaniel M. L. Arachidonic acid metabolism in isolated pancreatic islets. IV. Negative ion-mass spectrometric quantitation of monooxygenase product synthesis by liver and islets. Biochim Biophys Acta. 1985 Jun 14;835(1):1–17. doi: 10.1016/0005-2760(85)90023-2. [DOI] [PubMed] [Google Scholar]
  37. Wallenburg H. C., Dekker G. A., Makovitz J. W., Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet. 1986 Jan 4;1(8471):1–3. doi: 10.1016/s0140-6736(86)91891-x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES